xmlns:atom="http://www.w3.org/2005/Atom" xmlns:atom="http://www.w3.org/2005/Atom"

Please note that the date you requested in the address for this web page is not an actual date upon which a change occurred to this item of legislation. You are being shown the legislation from , which is the first date before then upon which a change was made.

ANNEXU.K.

a

The purity indicated in this column was the minimum degree of purity of the active substance evaluated. The active substance in the product placed on the market can be of equal or different purity if it has been proven to be technically equivalent to the evaluated active substance.

b

Regulation (EC) No 470/2009 of the European Parliament and of the Council of 6 May 2009 laying down Community procedures for the establishment of residue limits of pharmacologically active substances in foodstuffs of animal origin, repealing Council Regulation (EEC) No 2377/90 and amending Directive 2001/82/EC of the European Parliament and of the Council and Regulation (EC) No 726/2004 of the European Parliament and of the Council (OJ L 152, 16.6.2009, p. 11).

c

Regulation (EC) No 396/2005 of the European Parliament and of the Council of 23 February 2005 on maximum residue levels of pesticides in or on food and feed of plant and animal origin and amending Council Directive 91/414/EEC (OJ L 70, 16.3.2005, p. 1).

Common NameIUPAC NameIdentification NumbersMinimum degree of purity of the active substanceaDate of approvalExpiry date of approvalProduct typeSpecific conditions
Cypermethrin

IUPAC Name:

Cypermethrin cis:trans 40:60; (RS)-α-cyano-3 phenoxybenzyl-(1RS)-cis,trans-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropane carboxylate

EC No: 257-842-9

CAS No: 52315-07-8

≥ 92 % w/w

Isomeric ratio: cis:trans 40:60

1 June 202031 May 203018

The authorisations of biocidal products are subject to the following conditions:

1.

The product assessment shall pay particular attention to the exposures, the risks and the efficacy linked to any uses covered by an application for authorisation, but not addressed in the Union-level risk assessment of the active substance.

2.

In view of the risks identified for the uses assessed, the product assessment shall pay particular attention to:

a)

professional users;

b)

secondary exposure of infants and toddlers;

c)

surface water for:

i)

surface application indoors; and

ii)

outdoor wall and perimeter applications in urban areas;

d)

soil for:

i)

surface application indoors;

ii)

outdoor wall applications in urban and rural areas; and

iii)

perimeter applications in rural areas;

e)

sediment for:

i)

surface application, chemical barrier and crack and crevice treatment indoors; and

ii)

outdoor wall and perimeter applications in urban areas;

f)

groundwater for outdoor wall and perimeter applications in urban areas.

3.

For products that may lead to residues in food or feed, the need to set new or to amend existing maximum residue levels (MRLs) in accordance with Regulation (EC) No 470/2009 of the European Parliament and of the Councilb or Regulation (EC) No 396/2005 of the European Parliament and of the Councilc shall be verified, and any appropriate risk mitigation measures shall be taken to ensure that the applicable MRLs are not exceeded.